Načítá se...
What have we learned about CKD-MBD From the EVOLVE and PRIMO trials?
PURPOSE OF REVIEW: The treatment of CKD-MBD (Chronic Kidney Disease-Mineral Bone Disorder) has traditionally focused on improvement in biochemical parameters of the disease. However, studies evaluating hard clinical end points or surrogate end points are limited. RECENT FINDINGS: Two randomized tria...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3983668/ https://ncbi.nlm.nih.gov/pubmed/24100218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MNH.0b013e328365b3a3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|